Carb control is an advanced formula providing comprehensive glycemic and metabolic management support.* Three powerful blends in this formula include:
Prenulin® — a patented formulation of L-Arabinose and Chromax® — has been clinically proven to aid in reducing the body’s ability to absorb sugar, thereby lowering glucose and insulin impact by almost 30%.* The L-Arabinose in Prenulin® works by reducing the activity of the digestive enzyme responsible for sucrose digestion while Chromax, the most clinically studied form of chromium on the market, aids in healthy glucose metabolism.*
Phase 2 Carb Controller® is an all-natural, non-stimulant, white kidney bean extract clinically shown to help delay the digestion and absorption of dietary starches by temporarily inhibiting salivary and pancreatic alpha-amylase.* In conjunction with a sensible diet and exercise program, Phase 2® may assist in weight control.*
InnoSlim® is a patented, all-natural ingredient derived from Panax notoginseng and Astragalus membranaceus using proprietary extraction and processing technologies. InnoSlim® has been shown to help decrease circulating glucose and may reduce glucose absorption in the intestine while reducing fat accumulation.*
Three Capsules Contain:
L-Arabinose and Chromium†
|
1000 mg
|
Phaseolus vulgaris (white kidney bean) extract††
|
1000 mg
|
Panax ginseng (root) extract and Astragalus membranaceus (root) extract‡
|
100 mg
|
Other Ingredients: Hydroxypropyl methylcellulose (vegetable capsule), microcrystalline cellulose, bamboo silica.
Does Not Contain: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soy.
Caution: Keep out of reach of children.
Storage: Keep tightly closed in a cool, dry place.
†Prenulin® is a registered trademark of Pharmachem Laboratories, Inc. U.S. Patent 3,024,064.
†Chromax® is a registered trademark of Nutrition21, U.S. Patent 1,837,663.
††Phase 2 Carb Controller® is a registered trademark of Pharmachem Laboratories, Inc. U.S. Patent 4,133,494.
†††InnoSlim® is a registered trademark of Nuliv Science USA, Inc. U.S. Patent 4,161,195.